P

Inventor

LEVY RUTH

IL36 patents
⚠️ This page may combine multiple inventors who share the name “LEVY RUTH”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

TEVA PHARMA

21 patents
US5891923AApr 6, 1999

R-enantiomer of N-propargyl-1-aminoindan for the treatment of dementia

TEVA PHARMA97 citations99
US5519061AMay 21, 1996

R-enantiomer of n-propargyl-1-aminoindan, salts, compositions and uses thereof

TEVA PHARMA139 citations99
US5457133AOct 10, 1995

R-enantiomers of N-propargyl-aminoindan compounds, their preparation and pharmaceutical compositions containing them

TEVA PHARMA112 citations99
US6630514B2Oct 7, 2003

Use of R-enantiomer of N-propargyl-1-aminoindan, salts, and compositions thereof

TEVA PHARMA77 citations98
US5786390AJul 28, 1998

Pharmaceutical compositions of the R-enantiomer of N-propargyl -1-aminoindan

TEVA PHARMA105 citations98
US5532415AJul 2, 1996

R-enantiomer of N-propargyl-1-aminoindan, salts, compositions and uses thereof

TEVA PHARMA169 citations98
US5744500AApr 28, 1998

Use of R-enantiomer of N-propargyl-1-aminoindan, salts, and compositions thereof

TEVA PHARMA100 citations97
US5668181ASep 16, 1997

Use of the R-enantiomers of N-propargyl-1-aminoindan compounds for the treatment of depression

TEVA PHARMA92 citations97
US5599991AFeb 4, 1997

Esylate and sulfate salts of R(+)-N-propargyl-1-aminoindan

TEVA PHARMA84 citations97
US5576353ANov 19, 1996

Method of treating memory disorders using R-enantiomers of N-propargyl-aminoindan compounds

TEVA PHARMA101 citations97
US5453446ASep 26, 1995

Use of the R-enantiomers of N-propargyl 1-aminoindan compounds for treating Parkinson's disease.

TEVA PHARMA104 citations97
US5387612AFeb 7, 1995

Use of the R-enantiomers of N-propargyl-1-aminoindan compounds for treating Parkinson's disease

TEVA PHARMA114 citations97
US6528685B2Mar 4, 2003

Compositions containing and methods of using 1-aminoindan and derivatives thereof and process for preparing optically active 1-aminoindan derivatives

TEVA PHARMA47 citations96
US6277886B1Aug 21, 2001

Pharmaceutical compositions comprising S-(−)-N-propargyl-1-aminoindan

TEVA PHARMA66 citations96
US5914349AJun 22, 1999

Compositions containing and methods of using 1-aminoindan and derivatives thereof and process for preparing optically active 1-aminoindan derivatives

TEVA PHARMA50 citations96
US5877221AMar 2, 1999

Compositions containing and methods of using 1-aminoindan and derivatives thereof and process for preparing optically active 1-aminoindan derivatives

TEVA PHARMA52 citations96
US5994408ANov 30, 1999

Compositions containing and methods of using 1-aminoindan and derivatives thereof and process for preparing optically active 1-aminoindan derivatives

TEVA PHARMA54 citations95
US5840756ANov 24, 1998

Pharmaceutical composition of L-DOPA ester

TEVA PHARMA98 citations92
US5486541AJan 23, 1996

Monofluorinated derivatives of N-propargyl-1-aminoindan and their use as inhibitors of monoamine oxidase

TEVA PHARMA114 citations92
US7396860B2Jul 8, 2008

Use of rasagiline with or without riluzole to treat amyotrophic lateral sclerosis

TEVA PHARMA43 citations91
US6492426B1Dec 10, 2002

Use of 1-aminoindan derivatives for treatment of mania in bipolar mood disorder

TEVA PHARMA4 citations54

TYCO HEALTHCARE RETAIL SERV AG

9 patents

TECHNION RES & DEV FOUNDATION

2 patents

FIRST QUALITY RETAIL SERVICES

2 patents

BLAUGRUND ERAN

2 patents